Who is sponsoring NCT04262947?

NCT04262947 is sponsored by Lahey Clinic.

What drugs are being tested in NCT04262947?

Interventions in NCT04262947: Near Infrared Vein Imaging, Conventional IV placement.

What condition does NCT04262947 study?

NCT04262947 studies Catheterization, Peripheral.

Is NCT04262947 still recruiting?

NCT04262947 is currently terminated. Last updated 4 March 2022.

Are results published for NCT04262947?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-03-04 · How we verify

NCT04262947

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

Terminated NA Results posted Last updated 4 March 2022

What this trial tests

NA trial testing Near Infrared Vein Imaging in Catheterization, Peripheral in 38 participants. Terminated before completion.

Timeline

22 January 2020

Primary endpoint
1 April 2020

1 April 2020

Quick facts

Lead sponsor	Lahey Clinic
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	other
Enrollment	38
Start date	22 January 2020
Primary completion	1 April 2020
Estimated completion	1 April 2020
Sites	1 location across United States

Drugs / interventions tested

Near Infrared Vein Imaging
Conventional IV placement

Conditions studied

Catheterization, Peripheral — all drugs for Catheterization, Peripheral →

Sponsor

Lahey Clinic

Who can join

15 and older, any sex, with Catheterization, Peripheral. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Successful Initial IV Placement Primary · up to 30 minutes

Rate of successful initial placement of a peripheral venous catheter (investigators have up to 30 minutes or ONE attempt before the study allows for change of technique to the preference of the Vascular Access Team member)

Group	Value	95% CI
Conventional Method	10
VeinViewer Visualization Only	6
Constant Imaging With VeinViewer	6

Sponsor's own description

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in 'difficult' access patients using traditional peripheral venous catheter placement compared to two established methods utilizing NIR vein imaging. The investigators hypothesize that the capability to successfully place lasting peripheral venous catheters is increased with the adjunct of the imaging technology, reducing the number of failed needle sticks, reducing the number of peripheral venous catheters placed throughout a patient's hospital stay, and reducing the need for more invasive catheters such as PICC lines.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Catheterization, Peripheral

Currently open trials in the same condition.

NCT06905119 — Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience · NA · recruiting
NCT04856826 — Placement of Peripheral Venous Catheters Under Echo Guidance in a Post-emergency Medical Service · NA · recruiting

Other Lahey Clinic trials

Trials by the same sponsor.

NCT06868589 — Reducing Pain With Methadone and Ketamine in Liver Transplant · Phase 4 · active not recruiting
NCT07187063 — Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer · NA · recruiting
NCT04844970 — Anamorelin Study for Advanced Pancreatic Cancer · Phase 2 · terminated
NCT04077749 — Probiotic Bladder Instillation for Prevention of Catheter Associated UTIs in Chronically Catheterized Patients · EARLY_PHASE1 · withdrawn
NCT05993195 — Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04262947 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lahey Clinic
Last refreshed: 4 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04262947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing